Date

2021-03-30

Protocol

Protocol changed

Item Changed

Target number/sample size

Previous Version

2100 subjects in Sri Lanka (Ratio 2:1: 1400 in TDV arm, 700 in placebo arm), 20100 subjects globally

Next Version

2100 subjects in Sri Lanka (Ratio 2:1: 1400 in TDV arm, 700 in placebo arm), 20100 subjects globally 10500 globally for booster phase